SAGE Publications: Clinical Trials: Table of Contents
Clinical Trials, Ahead of Print. This article reviews the implementation challenges to the American Society of Clinical Oncology’s ethical framework for including research biopsies in oncology clinical trials. The primary challenges to implementation relate to the definitions of secondary endpoints, the scientific and regulatory framework, and the...
Clinical Trials, Ahead of Print. Background/aimsWhen designing a cluster randomized trial, advantages and disadvantages of tentative designs must be weighed. The stepped wedge design is popular for multiple reasons, including its potential to increase power via improved efficiency relative to a parallel-group design. In many realistic settings, it...
Clinical Trials, Ahead of Print. In the last few years, numerous novel designs have been proposed to improve the efficiency and accuracy of phase I trials to identify the maximum-tolerated dose (MTD) or the optimal biological dose (OBD) for noncytotoxic agents. However, the conventional 3+3 approach, known for its and poor performance, continues to...
Clinical Trials, Ahead of Print. BackgroundThe current endpoints for therapeutic trials of hospitalized COVID-19 patients capture only part of the clinical course of a patient and have limited statistical power and robustness.MethodsWe specify proportional odds models for repeated measures of clinical status, with a common odds ratio of lower severity...
Clinical Trials, Ahead of Print. Randomization and blinding are regarded as the most important tools to help reduce bias in clinical trial designs. Randomization is used to help guarantee that treatment arms differ systematically only by treatment assignment at baseline, and blinding is used to ensure that differences in endpoint evaluation and clinical...
Clinical Trials, Ahead of Print. BackgroundThe Early Phase Cancer Prevention Clinical Trials Program (Consortia), led by the Division of Cancer Prevention, National Cancer Institute, supports and conducts trials assessing safety, tolerability, and cancer preventive potential of a variety of interventions. Accrual to cancer prevention trials includes...
Build your own newsfeed
Ready to give it a go?
Start a 14-day trial, no credit card required.